CURRENT BUSINESS AFFAIRS

TOPIC
GLENMARK LIFE SCIENCES IPO

PRESENTED BY
ANEESH SAI MUNTA
COMPANY OVERVIEW

GLENMARK LIFE SCIENCES

Glenmark Life Sciences is a leading developer and manufacturer of select high value,
non-commoditized Active Pharmaceutical Ingredients (APIs) in chronic therapeutic areas.
• As on March 31, 2021, Glenmark Life Sciences had a portfolio of 120 molecules globally,
with top 10 products account for 66.36% of the revenue.
• Besides domestic sales, the company exports to countries in Europe, North America,
Latin America, besides nations in other parts of the world including Japan.
• Top five customers including parent Glenmark Pharma, accounting for 55.8% of the
revenue.
• 16 of the 20 largest generic companies are its customers.
COMPANY FINANCIALS

Total income grew at a compounded

annual rate of 15.84% over the last three
years, while net profit rose at 17.35%.

The company maintained a margin of

around 30% range during the period.
IPO

Bulk drug and contract manufacturer

Glenmark Life Sciences Ltd. will launch
its initial public offering on July 27

Glenmark Life Sciences will sell shares at Rs 695-720 apiece, seeking a market value of Rs 8,822 crore at the upper end
of the price band. The offer comprises a fresh issue of Rs 1,060 crore and sale of shares worth Rs 453.6 crore by parent
Glenmark Pharmaceuticals Ltd.,

The promoter shareholding will fall to 83% after the offer, while the rest will be held by the public
ISSUE DETAILS

ISSUE SHARE PRICE

OPEN/CLOSES
July 27/29 Rs.695-720 a piece

1 6
ISSUE SIZE LISTING
Up to Rs.1,513.6 crore
2 5 BSE AND NSE

FACE VALUE
3 4 LOT SIZE
Rs.2 per share 20 shares and multiples
OBJECTIVES

Glenmark Life Sciences

plans to use Rs 800 crore Glenmark Life
from the IPO proceeds to Sciences also
pay the parent for the plans to set up a
acquisition of the active greenfield facility in
pharmaceutical ingredient Solapur,
business in 2018. The Maharashtra to double its
company had sold the unit capacity by 2024.
at a slump-sale value of Rs
1,100 crore.

The remaining
A company will use
Rs.155 crore for
amount will be used
brownfield capital at its
for other general
Dahej facility to enhance purposes.
the total installed
capacity by 200 Kiloleter
THANK YOU